• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体药代动力学分析中协变量模型的一种进化搜索算法。

An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis.

作者信息

Yamashita Fumiyoshi, Fujita Atsuto, Sasa Yukako, Higuchi Yuriko, Tsuda Masahiro, Hashida Mitsuru

机构信息

Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshidashimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshidashimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

出版信息

J Pharm Sci. 2017 Sep;106(9):2407-2411. doi: 10.1016/j.xphs.2017.04.029. Epub 2017 Apr 25.

DOI:10.1016/j.xphs.2017.04.029
PMID:28450239
Abstract

Building a covariate model is a crucial task in population pharmacokinetics. This study develops a novel method for automated covariate modeling based on gene expression programming (GEP), which not only enables covariate selection, but also the construction of nonpolynomial relationships between pharmacokinetic parameters and covariates. To apply GEP to the extended nonlinear least squares analysis, the parameter consolidation and initial parameter value estimation algorithms were further developed and implemented. The entire program was coded in Java. The performance of the developed covariate model was evaluated for the population pharmacokinetic data of tobramycin. In comparison with the established covariate model, goodness-of-fit of the measured data was greatly improved by using only 2 additional adjustable parameters. Ten test runs yielded the same solution. In conclusion, the systematic exploration method is a potentially powerful tool for prescreening covariate models in population pharmacokinetic analysis.

摘要

构建协变量模型是群体药代动力学中的一项关键任务。本研究基于基因表达式编程(GEP)开发了一种用于自动协变量建模的新方法,该方法不仅能够进行协变量选择,还能构建药代动力学参数与协变量之间的非多项式关系。为了将GEP应用于扩展的非线性最小二乘分析,进一步开发并实现了参数合并和初始参数值估计算法。整个程序用Java编码。针对妥布霉素的群体药代动力学数据评估了所开发的协变量模型的性能。与已建立的协变量模型相比,仅使用另外2个可调参数就大大提高了实测数据的拟合优度。十次测试运行得出了相同的结果。总之,该系统探索方法是群体药代动力学分析中预筛选协变量模型的一种潜在强大工具。

相似文献

1
An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis.群体药代动力学分析中协变量模型的一种进化搜索算法。
J Pharm Sci. 2017 Sep;106(9):2407-2411. doi: 10.1016/j.xphs.2017.04.029. Epub 2017 Apr 25.
2
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.应用单目标混合遗传算法方法进行药代动力学模型构建。
J Pharmacokinet Pharmacodyn. 2012 Aug;39(4):393-414. doi: 10.1007/s10928-012-9258-0. Epub 2012 Jul 6.
3
Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models.用于非线性混合效应药代动力学模型中协变量模型构建的调整自适应套索法
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):55-66. doi: 10.1007/s10928-017-9504-6. Epub 2017 Jan 31.
4
Effect of correlation on covariate selection in linear and nonlinear mixed effect models.相关性对线性和非线性混合效应模型中协变量选择的影响。
Pharm Stat. 2017 Jan;16(1):45-54. doi: 10.1002/pst.1776. Epub 2016 Sep 1.
5
The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.临床无关标准在协变量模型构建中的应用及在多非利特药代动力学数据中的应用
J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):503-26. doi: 10.1007/s10928-008-9099-z. Epub 2008 Nov 15.
6
The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.套索法——一种用于非线性混合效应模型中预测协变量模型构建的新方法。
J Pharmacokinet Pharmacodyn. 2007 Aug;34(4):485-517. doi: 10.1007/s10928-007-9057-1. Epub 2007 May 22.
7
Design of pharmacokinetic studies for latent covariates.潜伏协变量的药代动力学研究设计。
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):87-97. doi: 10.1007/s10928-011-9231-3. Epub 2011 Dec 10.
8
A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach.一种基于无偏相关性检验的新型方法,用于非线性混合效应模型中的协变量选择:COSSAC 方法。
CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):318-329. doi: 10.1002/psp4.12612.
9
Nonparametric goodness-of-fit testing for parametric covariate models in pharmacometric analyses.非参数拟合优度检验在药物代谢动力学分析中的参数协变量模型。
CPT Pharmacometrics Syst Pharmacol. 2021 Jun;10(6):564-576. doi: 10.1002/psp4.12614. Epub 2021 Jun 4.
10
Extended least squares (ELS) for pharmacokinetic models.药代动力学模型的扩展最小二乘法(ELS)
J Pharm Sci. 1987 Jul;76(7):565-71. doi: 10.1002/jps.2600760716.

引用本文的文献

1
Covariate Model Selection Approaches for Population Pharmacokinetics: A Systematic Review of Existing Methods, From SCM to AI.群体药代动力学的协变量模型选择方法:从结构方程模型到人工智能的现有方法系统综述
CPT Pharmacometrics Syst Pharmacol. 2025 Apr;14(4):621-639. doi: 10.1002/psp4.13306. Epub 2025 Jan 20.
2
Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls.开发预测统计模型,以深入了解药品召回事件。
AAPS PharmSciTech. 2024 Oct 23;25(8):255. doi: 10.1208/s12249-024-02970-z.
3
Parameter grouping and co-estimation in physiologically based kinetic models using genetic algorithms.
基于遗传算法的生理动力学模型中的参数分组和共同估计。
Toxicol Sci. 2024 Jun 26;200(1):31-46. doi: 10.1093/toxsci/kfae051.
4
Recent applications of quantitative systems pharmacology and machine learning models across diseases.近年来定量系统药理学和机器学习模型在多种疾病中的应用。
J Pharmacokinet Pharmacodyn. 2022 Feb;49(1):19-37. doi: 10.1007/s10928-021-09790-9. Epub 2021 Oct 20.
5
The future of antimicrobial dosing in the ICU: an opportunity for data science.重症监护病房抗菌药物给药的未来:数据科学的机遇。
Intensive Care Med. 2021 Dec;47(12):1481-1483. doi: 10.1007/s00134-021-06549-1. Epub 2021 Oct 11.
6
An automated approach to identify scientific publications reporting pharmacokinetic parameters.一种识别报告药代动力学参数的科学出版物的自动化方法。
Wellcome Open Res. 2021 Apr 21;6:88. doi: 10.12688/wellcomeopenres.16718.1. eCollection 2021.
7
An artificial neural network-pharmacokinetic model and its interpretation using Shapley additive explanations.人工神经网络-药代动力学模型及其使用 Shapley 加法解释的解释。
CPT Pharmacometrics Syst Pharmacol. 2021 Jul;10(7):760-768. doi: 10.1002/psp4.12643. Epub 2021 May 27.
8
Machine Learning in Drug Discovery and Development Part 1: A Primer.机器学习在药物发现和开发中的应用(一):概论。
CPT Pharmacometrics Syst Pharmacol. 2020 Mar;9(3):129-142. doi: 10.1002/psp4.12491. Epub 2020 Mar 11.